---
title: "Photocure ASA to Release Q4 and Full Year 2024 Financial Results"
date: "2025-02-12 21:33:11"
summary: "Maximize Your Portfolio with Data Driven Insights:Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions. Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart PortfolioThe latest announcement is out from..."
categories:
  - "tipranks_announcements"
lang:
  - "en"
translations:
  - "en"
tags:
  - "tipranks_announcements"
menu: ""
thumbnail: "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_390599908-1-750x406.jpg"
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

### Maximize Your Portfolio with Data Driven Insights:

* Leverage the power of [TipRanks' Smart Score](https://www.tipranks.com/screener/top-smart-score-stocks), a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
* Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with  [Your Smart Portfolio](https://www.tipranks.com/smart-portfolio/holdings)

The latest announcement is out from Photocure ASA ( [(PHCUF)](https://www.tipranks.com/stocks/phcuf) ).

Photocure ASA is set to announce its financial results for the fourth quarter and the preliminary full year of 2024 on February 19, 2025. The report and a live investor presentation, hosted by CEO Dan Schneider and CFO Erik Dahl, will be publicly available on the company’s website. This announcement is crucial for stakeholders as it provides insights into the company’s financial health and strategic direction.

**More about Photocure ASA**

Photocure ASA, known as The Bladder Cancer Company, is a Norwegian firm that provides innovative solutions to enhance the treatment of bladder cancer patients. Their proprietary technology highlights cancer cells by making them glow bright pink, contributing significantly to improved health outcomes globally. Photocure is headquartered in Oslo and is listed on the Oslo Stock Exchange under the ticker PHO.

**YTD Price Performance:** -4.89%

**Average Trading Volume:** 1,008

**Technical Sentiment Consensus Rating:** Buy

**Current Market Cap:** $138.7M

See more data about PHCUF stock on [TipRanks’ Stock Analysis page](https://www.tipranks.com/stocks/phcuf/stock-analysis).

Trending Articles:
------------------

* [SUI Lawsuit Alert! Class Action Against Sun Communities, Inc.](https://www.tipranks.com/news/sui-lawsuit-alert-class-action-against-sun-communities-inc)
* [Meta Stock Alert! Wins New Street-High Price Target from Tigress Financial](https://www.tipranks.com/news/meta-stock-alert-wins-new-street-high-price-target-from-tigress-financial)
* [Buffett’s Berkshire Ups Occidental Stake to 28.3% by Buying More Shares](https://www.tipranks.com/news/buffetts-berkshire-ups-occidental-stake-to-28-3-by-buying-more-shares)

[tipranks_announcements](https://www.tipranks.com/news/company-announcements/photocure-asa-to-release-q4-and-full-year-2024-financial-results)
